Nature Cancer

🌷Our April Issue is out! Featuring: ☑️Our Series on Tumor Heterogeneity and Plasticity ☑️CAR T cell therapy in solid tumors ☑️An erythrocyte–anti-PD1 conjugate ☑️Pediatric tumors classification using cfDNA methylation and more! nature.com/natcancer/volu…

⭐Out today! Read the phase I clinical trial on neoantigen DNA vaccine for patients with glioblastoma nature.com/articles/s4301…

⭐️Check out the Perspective on cellular neighborhoods in cancer by @LichunMa, @KaiTanLab1 & co 🔗nature.com/articles/s4301… Part of our Series on Tumor Heterogeneity and Plasticity: nature.com/collections/gf…

A phase 1 clinical trial now published @naturecancer 'Tumor-localized CD40 agonism with MP0317, a FAP x CD40 DARPin, reprograms the tumor microenvironment in patients with advanced solid tumors' ✒️By Hilde De Winter & colleagues 🔗nature.com/articles/s4301…

⭐️Don't miss this Review published @NatureCancer as part of our Series on Tumor Heterogeneity and Plasticity 'Heterogeneity and plasticity of cancer-associated fibroblasts' ✒️By Ruth Scherz-Shouval, Mara Sherman and co-authors 🔗nature.com/articles/s4301…

🔥Online now, a Review on EMT as driver of tumor cell plasticity By @NietoAngela and @ruljc Part of our Series on Tumor Heterogeneity and Plasticity: nature.com/collections/gf… nature.com/articles/s4301…

Our Senior Editor Julieta Alfonso is excited to join the Europe's Cancer Immunotherapy CIMT Annual Meeting on May 11-13 2026 in Mainz. Please reach out to her if you are around! meeting.cimt.eu

📢Today we launch our Series on Tumor Heterogeneity and Plasticity featuring commissioned Reviews and a selection of articles published in Nature Cancer! Read about EMT, CAF plasticity, immune cell plasticity, cellular neighborhoods and more here: 🔗nature.com/collections/gf…

Reframing Precision Medicine tackles a defining challenge: how do we implement precision medicine at scale? Attend to: - Gain real-world insight. - Explore AI & multi-omics. - Connect across the ecosystem. Early bird ends 30 April → save up to £400: go.nature.com/4tx2ZBP

📰Now on Nature Cancer: Li and colleagues show a dual STING/PI3Kγ nano‑therapy counters immune suppression in pancreatic cancer, activating myeloid cells, limiting regulatory B cells, and improving immunotherapy efficacy #cancer 👉nature.com/articles/s4301…

Our Senior Editor Julieta Alfonso will be attending #TumorMetabolism : Diet, #Microbiome and Beyond, this June in Killarney with @KeystoneSymp! Looking forward to big ideas, bold science, and great conversations. keysym.us/KSTumorMetab26 #KSTumorMetab26

From November 11-12, we're bringing together global experts, researchers, clinicians, policymakers, and patient advocates to discuss challenges and research improving survival outcomes for childhood cancer patients @Vin_Giacco Free to register: go.nature.com/4sS5kpJ

🌟New Perspective out today presents the recent advances in predicting TCR–epitope recognition and the therapeutic applications in cancer immunotherapy. by @GfellerD and colleagues 🔗nature.com/articles/s4301…

🌟Now in Nature Cancer, multi-omics analysis of nasopharyngeal carcinoma identifies molecular subtypes with distinct immune profiles and responses to induction chemotherapy. 🖊️by Jia-Xing Yue, Na Liu, Aihua Sun, Jun Ma & Fuchu He and colleagues nature.com/articles/s4301…

🌟New study in Nature Cancer evaluates the clinical significance of early PSMA upregulation in patients with metastatic castrate-resistant prostate cancer treated with enzalutamide with or without 177Lu-PSMA-617. by @drlouiseemmett & colleagues nature.com/articles/s4301…

Article now online @NatureCancer 'Leptomeningeal metastatic cancer cells induce a permissive choroid plexus vasculature through extracellular-vesicle-derived 5-HIAA signaling' ✒️By Yudan Chi and colleagues 🔗 nature.com/articles/s4301…

New REVIEW published @NatureCancer ! 'Single-cell and spatial profiling in cancer biology and clinical oncology' ✏️By Benjamin Izar, Elham Azizi and co-authors 🔗nature.com/articles/s4301…

🗒️Technical Report now published @NatureCancer 'PRET is a few-shot system for pan-cancer recognition without example training' By Xiaomeng Li, Kang Zhang, Qingling Zhang & colleagues 🔗 nature.com/articles/s4301…

🚨Our March issue is now live! Have a look at Nature Cancer issue featuring ✅HER2+ breast cancer ✅TNBC & immunotherapy ✅Proteomic imaging ✅m6A epitranscriptomics ✅AI in breast screening ✅GENEVA platform models ...and more... nature.com/natcancer/volu…

🌟Out today at Nature Cancer Stromal cells and chemokine gradients organize the loss of tissue architecture in lymph nodes in B cell lymphoma by Judith B. Zaugg, Daniel Hübschmann, Simon Haas & Sascha Dietrich & co nature.com/articles/s4301…